Stepana Boukalova

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 8

Top Topics

Transforming Growth Factor

Squamous Cell Carcinoma

Positive Breast Cancer

Ischemia Reperfusion Injury

Top Venues

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Pankaj Sharma, Elena Maklashina, Markus W Voehler, Sona Balintova, Sarka Dvorakova, Michal Kraus, Katerina Hadrava Vanova, Zuzana Nahacka, Renata Zobalova, Stepana Boukalova, Kristýna Čunátová, Tomas Mracek, Hans K Ghayee, Karel Pacak, Jakub Rohlena, Jiri Neuzil, Gary Cecchini, Tina M Iverson
Disordered-to-ordered transitions in assembly factors allow the complex II catalytic subunit to switch binding partners. Nature communications 15 (1) (2024)
Pankaj Sharma, Elena Maklashina, Markus W Voehler, Sona Balintova, Sarka Dvorakova, Michal Kraus, Katerina Hadrava Vanova, Zuzana Nahacka, Renata Zobalova, Stepana Boukalova, Kristýna Čunátová, Tomas Mracek, Hans K Ghayee, Karel Pacak, Jakub Rohlena, Jiri Neuzil, Gary Cecchini, Tina M Iverson
Disordered-to-ordered transitions in assembly factors allow the complex II catalytic subunit to switch binding partners. Nature communications 15 (1) (2024)
Pankaj Sharma, Elena Maklashina, Markus W Voehler, Sona Balintova, Sarka Dvorakova, Michal Kraus, Katerina Hadrava Vanova, Zuzana Nahacka, Renata Zobalova, Stepana Boukalova, Kristýna Čunátová, Tomas Mracek, Hans K Ghayee, Karel Pacak, Jakub Rohlena, Jiri Neuzil, Gary Cecchini, Tina M Iverson
Disordered-to-ordered transitions in assembly factors allow the complex II catalytic subunit to switch binding partners. Nature communications 15 (1) (2024)
Pankaj Sharma, Elena Maklashina, Markus W Voehler, Sona Balintova, Sarka Dvorakova, Michal Kraus, Katerina Hadrava Vanova, Zuzana Nahacka, Renata Zobalova, Stepana Boukalova, Kristýna Čunátová, Tomas Mracek, Hans K Ghayee, Karel Pacak, Jakub Rohlena, Jiri Neuzil, Gary Cecchini, Tina M Iverson
Disordered-to-ordered transitions in assembly factors allow the complex II catalytic subunit to switch binding partners. Nature communications 15 (1) (2024)
Pankaj Sharma, Elena Maklashina, Markus W Voehler, Sona Balintova, Sarka Dvorakova, Michal Kraus, Katerina Hadrava Vanova, Zuzana Nahacka, Renata Zobalova, Stepana Boukalova, Kristýna Čunátová, Tomas Mracek, Hans K Ghayee, Karel Pacak, Jakub Rohlena, Jiri Neuzil, Gary Cecchini, Tina M Iverson
Disordered-to-ordered transitions in assembly factors allow the complex II catalytic subunit to switch binding partners. Nature communications 15 (1) (2024)
Pankaj Sharma, Elena Maklashina, Markus W Voehler, Sona Balintova, Sarka Dvorakova, Michal Kraus, Katerina Hadrava Vanova, Zuzana Nahacka, Renata Zobalova, Stepana Boukalova, Kristýna Čunátová, Tomas Mracek, Hans K Ghayee, Karel Pacak, Jakub Rohlena, Jiri Neuzil, Gary Cecchini, Tina M Iverson
Disordered-to-ordered transitions in assembly factors allow the complex II catalytic subunit to switch binding partners. Nature communications 15 (1) (2024)
Pankaj Sharma, Elena Maklashina, Markus W Voehler, Sona Balintova, Sarka Dvorakova, Michal Kraus, Katerina Hadrava Vanova, Zuzana Nahacka, Renata Zobalova, Stepana Boukalova, Kristýna Čunátová, Tomas Mracek, Hans K Ghayee, Karel Pacak, Jakub Rohlena, Jiri Neuzil, Gary Cecchini, Tina M Iverson
Disordered-to-ordered transitions in assembly factors allow the complex II catalytic subunit to switch binding partners. Nature communications 15 (1) (2024)
Zuzana Ezrova, Zuzana Nahacka, Jan Stursa, Lukas Werner, Erik Vlcak, Petra Kralova Viziova, Michael V Berridge, Radislav Sedlacek, Renata Zobalova, Jakub Rohlena, Stepana Boukalova, Jiri Neuzil
SMAD4 loss limits the vulnerability of pancreatic cancer cells to complex I inhibition via promotion of mitophagy. Oncogene 40 (14) (2021)